Texas judge strikes down major Obamacare provision; one scientist's quest to understand the diversity of brains

A federal judge Thursday reversed a major Obamacare provision requiring plans to cover preventive care.

March 30, 2023 Check out STAT+

Sponsored By

Adobe Texas judge strikes down major Obamacare provision protecting preventive care The ruling deals a massive blow to President Biden's efforts to lower maternal and infant mortality rates and bolster reproductive rights. By Sarah Owermohle STAT+ | FDA proposes a new plan to streamline updates to medical devices that use AI The FDA has released a new plan allowing developers of medical devices that rely on AI to automatically update tools already on the market. By Casey Ross STAT+ | Former J&J exec, an in-demand free agent, takes the helm at privately held FogPharma Mammen, previously a candidate for the top job at Biogen, brings experience at both tiny biotech startups and multinational pharma giants. By Damian Garde Olivia Obineme for STAT In the whitewashed world of Alzheimer's research, one scientist is on a quest to understand the diversity of brains Barnes' work "helps us not just understand Alzheimer's disease in Black people but Alzheimer's disease in general." By Usha Lee McFarling STAT+ | Drug middlemen switch tactics, but the outcome is the same: high prices Prescription drug middlemen are shifting from rebates to increasingly larger administrative fees and specialty-generic markups. By John Wilkerson STAT+ | Is there $21 billion left for Covid response, or $5 billion? The White House is using fuzzy math How much money does the federal government still have set aside for the Covid response? It depends who you ask. By Rachel Cohrs Sammy Kimball for STAT Listen: Biotech's monkey shortage, the broken generics market, & conference cancel culture This week, we explain how biotech is affected by a strange situation involving smuggled monkeys, international intrigue, and a criminal probe. By Damian Garde and Meg Tirrell and Adam Feuerstein Opinion: To deal with the next pandemic, the FDA needs an Office of Preparedness and Response It would be naive to think that the FDA could respond to an H5N1 flu epidemic as quickly as it did Covid in 2020. By Robert Kadlec and Enlli Lewis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser